Form 4: SANUWAVE Health CFO Acquires Stock Options in Lieu of Bonus

Peter Sorensen, CFO of SANUWAVE Health, Inc., acquired stock options in lieu of a portion of his 2024 annual cash bonus on January 31, 2025.

Summary

• Peter Sorensen, the Chief Financial Officer of SANUWAVE Health, Inc., filed a Form 4 on February 7, 2025, reporting a transaction that occurred on January 31, 2025.
• Sorensen acquired 260 stock options with an exercise price of $27.70.
• These options, fully vested at the grant date, were granted in lieu of a portion of his 2024 annual cash bonus.
• The options expire on January 31, 2030, and are exercisable for 260 shares of common stock at a price of $15.67 per share.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The grant of options in lieu of cash could be seen as slightly positive, indicating a focus on preserving cash.

Positives

• The acquisition of stock options by the CFO aligns his interests with those of the shareholders.
• The options being granted in lieu of cash bonus may preserve cash for the company.

Industry Context

Stock options are a common form of executive compensation, particularly in growth-oriented companies. This grant aligns the CFO's incentives with the long-term performance of SANUWAVE Health.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see this as a sign of the company managing its cash flow effectively.

Key Dates